Annual report pursuant to Section 13 and 15(d)

Restatement of Previously Filed Balance Sheet (Tables)

v3.22.1
Restatement of Previously Filed Balance Sheet (Tables)
12 Months Ended
Dec. 31, 2021
Restatement of Previously Filed Balance Sheet [Abstract]  
Revision on Financial Statements
The following table summarizes the effect of the revision on each financial statement line item as of the date indicated:

As of March 16, 2021
 
As Previously
Reported
   
Adjustment
   
As Restated
 
Total assets
 
$
347,026,800
   
$
-
   
$
347,026,800
 
Total current liabilities
 
$
980,160
   
$
-
   
$
980,160
 
Deferred underwriting commissions
   
12,075,000
     
-
     
12,075,000
 
Derivative warrant liabilities
   
-
     
26,150,000
     
26,150,000
 
Total liabilities
 
$
13,055,160
   
$
26,150,000
   
$
39,205,160
 
Class A ordinary shares subject to possible redemption
   
328,971,630
     
16,028,370
     
345,000,000
 
Preference shares
   
-
     
-
     
-
 
Class A ordinary shares
   
160
     
(160
)
   
-
 
Class B ordinary shares
   
863
     
-
     
863
 
Additional paid-in capital
   
5,044,057
     
(5,044,057
)
   
-
 
Accumulated deficit
   
(45,070
)
   
(37,134,153
)
   
(37,179,223
)
Total shareholders' equity (deficit)
 
$
5,000,010
   
$
(42,178,370
)
 
$
(37,178,360
)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Equity (Deficit)
 
$
347,026,800
   
$
-
   
$
347,026,800